Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

CEC levels may be a useful marker for predicting prostate cancer progression.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Early balding may be a sign of future prostate problems.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Castration significantly reduces prostate size and BPH symptoms.